TATYANA GABYAK: Open Payments
NPI 1124007786 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 9 payments from 8 companies in 2025. Trend: 2023 $513 · 2024 $387 · 2025 $961
Food & beverage: $961
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 2 | $246 |
| Calliditas Therapeutics US Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Amgen Inc. | 1 | $123 |
| Travere Therapeutics, Inc. | 1 | $114 |
| Mallinckrodt Hospital Products Inc. | 1 | $91 |
| Ethicon US, LLC | 1 | $14 |
Products named: Leqembi, TARPEYO, LOKELMA, Wegovy, TAVNEOS, Filspari, ACTHAR, Echelon Circular.
Industry payments across OH — which companies pay providers there.
